Overview
Clover Health Investments, Corp. is a healthcare technology company based in the United States. It operates primarily in the health insurance industry, focusing on Medicare Advantage plans. Clover Health leverages its proprietary technology platform, the Clover Assistant, to optimize provider decisions and assist in delivering better health outcomes at lower costs. The company's innovative approach integrates deep learning and data analytics to personalize healthcare at scale, actively serving the needs of elderly consumers with its insurance products. Key projects revolve around expanding its insurance offerings, enhancing its data-driven platform capabilities, and increasingly integrating preventive health measures to ensure comprehensive care for its growing customer base.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Clover Health Investments, Corp. as of June 30, 2025 is 1,607.90 MM.
- The operating income for Clover Health Investments, Corp. as of June 30, 2025 is -42.60 MM.
- The net income for Clover Health Investments, Corp. as of June 30, 2025 is -43.10 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 1,607.90 | -42.60 | -43.10 |
| 2025-03-31 | 1,486.54 | -24.39 | -25.11 |
| 2024-12-31 | 1,370.66 | -45.93 | -43.01 |
| 2024-09-30 | 2,115.22 | -77.55 | -91.39 |
| 2024-06-30 | 1,316.69 | -97.42 | -123.70 |
| 2024-03-31 | 1,285.71 | -129.22 | -159.93 |
| 2023-12-31 | 1,263.06 | -184.29 | -213.36 |
| 2023-09-30 | 1,863.62 | -242.64 | -227.12 |
| 2023-06-30 | 2,441.30 | -285.41 | -261.13 |
| 2023-03-31 | 2,988.97 | -365.23 | -336.68 |
| 2022-12-31 | 1,199.29 | -277.45 | -339.57 |
| 2022-09-30 | 3,040.58 | -440.91 | -442.54 |
| 2022-06-30 | 2,563.67 | -515.08 | -401.58 |
| 2022-03-31 | 2,075.29 | -592.99 | -614.83 |
| 2021-12-31 | 1,361.37 | -636.99 | -587.76 |
| 2021-09-30 | 1,158.30 | -517.83 | -526.95 |
| 2021-06-30 | 921.74 | -390.20 | -479.66 |
| 2021-03-31 | 720.55 | -185.16 | -156.65 |
| 2020-12-31 | 690.02 | -92.71 | -136.39 |
| 2020-09-30 | 623.56 | -87.20 | -88.67 |
Income Statement: EPS
- The earnings per share basic for Clover Health Investments, Corp. as of June 30, 2025 is -0.09.
- The earnings per share diluted for Clover Health Investments, Corp. as of June 30, 2025 is -0.09.
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | -0.09 | -0.09 |
| 2025-03-31 | -0.05 | -0.05 |
| 2024-12-31 | -0.09 | |
| 2024-09-30 | -0.19 | -0.18 |
| 2024-06-30 | -0.25 | -0.25 |
| 2024-03-31 | -0.33 | -0.33 |
| 2023-12-31 | -0.44 | |
| 2023-09-30 | -0.47 | -0.48 |
| 2023-06-30 | -0.55 | -0.55 |
| 2023-03-31 | -0.70 | -0.70 |
| 2022-12-31 | -0.71 | |
| 2022-09-30 | -0.96 | -0.96 |
| 2022-06-30 | -0.89 | -0.89 |
| 2022-03-31 | -1.41 | -1.41 |
| 2021-12-31 | -1.42 | |
| 2021-09-30 | -1.60 | -1.60 |
| 2021-06-30 | -2.01 | -2.01 |
| 2021-03-31 | -1.00 | -0.99 |
| 2020-12-31 | -1.54 | |
| 2020-09-30 | -1.15 | -1.15 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Clover Health Investments, Corp. as of June 30, 2025 is -46.73 MM.
- The cash from investing activities for Clover Health Investments, Corp. as of June 30, 2025 is 30.92 MM.
- The cash from financing activities for Clover Health Investments, Corp. as of June 30, 2025 is -50.31 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | -46.73 | 30.92 | -50.31 |
| 2025-03-31 | -7.38 | 0.31 | -45.74 |
| 2024-12-31 | 34.84 | 0.56 | -17.36 |
| 2024-09-30 | -108.62 | 85.67 | -40.84 |
| 2024-06-30 | -206.18 | 77.48 | -9.34 |
| 2024-03-31 | -197.76 | 139.02 | -6.29 |
| 2023-12-31 | -144.66 | 140.01 | -5.07 |
| 2023-09-30 | -178.37 | 69.01 | 78.23 |
| 2023-06-30 | -57.93 | 45.94 | 80.33 |
| 2023-03-31 | -150.27 | 68.80 | 80.93 |
| 2022-12-31 | -203.93 | 95.13 | -4.96 |
| 2022-09-30 | -74.73 | -24.01 | 279.35 |
| 2022-06-30 | -221.51 | -222.97 | 283.21 |
| 2022-03-31 | -246.50 | -141.46 | 257.28 |
| 2021-12-31 | -282.33 | -435.45 | 925.39 |
| 2021-09-30 | -262.05 | -261.40 | 635.99 |
| 2021-06-30 | -251.58 | -17.55 | 647.47 |
| 2021-03-31 | -174.19 | -202.58 | 668.79 |
| 2020-12-31 | -118.50 | 137.40 | 5.84 |
| 2020-09-30 | -125.52 | 110.62 | 7.00 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/e for Clover Health Investments, Corp. as of June 30, 2025 is -56.28.
- The p/book for Clover Health Investments, Corp. as of June 30, 2025 is 4.21.
- The p/tbv for Clover Health Investments, Corp. as of June 30, 2025 is 4.24.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | -56.28 | 4.21 | 4.24 |
| 2025-03-31 | 4.40 | 4.44 | |
| 2024-12-31 | 3.84 | 3.88 | |
| 2024-09-30 | -9.30 | 3.54 | 3.57 |
| 2024-06-30 | -4.04 | 2.21 | 2.23 |
| 2024-03-31 | 1.22 | 1.23 | |
| 2023-12-31 | -2.05 | 1.44 | 1.53 |
| 2023-09-30 | -2.03 | 1.60 | 1.70 |
| 2023-06-30 | -1.25 | 1.30 | 1.44 |
| 2023-03-31 | -1.20 | 1.04 | |
| 2022-12-31 | 1.13 | 1.14 | |
| 2022-09-30 | -2.02 | 1.90 | 1.92 |
| 2022-06-30 | 2.06 | 2.08 | |
| 2022-03-31 | -2.86 | 4.07 | 4.12 |
| 2021-12-31 | -3.33 | 5.57 | 5.65 |
| 2021-09-30 | -6.59 | 10.03 | 10.17 |
| 2021-06-30 | |||
| 2021-03-31 | -7.50 | 2.00 | 2.01 |
| 2020-12-31 | |||
| 2020-09-30 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for Clover Health Investments, Corp. as of June 30, 2025 is -0.02.
- The ebit (3y)/ev for Clover Health Investments, Corp. as of June 30, 2025 is -0.11.
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | -0.02 | -0.11 |
| 2025-03-31 | -0.04 | -0.14 |
| 2024-12-31 | -0.09 | -0.21 |
| 2024-09-30 | -0.13 | -0.29 |
| 2024-06-30 | -0.36 | -0.84 |
| 2024-03-31 | -0.79 | -1.41 |
| 2023-12-31 | -1.37 | -2.41 |
| 2023-09-30 | -1.19 | -1.74 |
| 2023-06-30 | -1.46 | -1.76 |
| 2023-03-31 | -1.12 | -1.22 |
| 2022-12-31 | -5.50 | -4.39 |
| 2022-09-30 | -0.79 | -0.67 |
| 2022-06-30 | -0.81 | -0.55 |
| 2022-03-31 | -0.42 | -0.24 |
| 2021-12-31 | -0.33 | -0.22 |
| 2021-09-30 | -0.18 | -0.07 |
| 2021-06-30 | ||
| 2021-03-31 | -0.12 | -0.17 |
| 2020-12-31 | ||
| 2020-09-30 |
Management Effectiveness
- The roa for Clover Health Investments, Corp. as of June 30, 2025 is -0.04.
- The roe for Clover Health Investments, Corp. as of June 30, 2025 is -0.08.
- The roic for Clover Health Investments, Corp. as of June 30, 2025 is -0.07.
- The croic for Clover Health Investments, Corp. as of June 30, 2025 is -0.16.
- The ocroic for Clover Health Investments, Corp. as of June 30, 2025 is -0.02.
| Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
| 2025-06-30 | -0.04 | -0.08 | -0.07 | -0.16 | -0.02 |
| 2025-03-31 | -0.06 | -0.15 | -0.12 | 0.05 | 0.10 |
| 2024-12-31 | -0.16 | -0.28 | -0.26 | -0.18 | -0.31 |
| 2024-09-30 | -0.12 | -0.38 | -0.38 | -0.42 | -0.54 |
| 2024-06-30 | -0.11 | -0.49 | -0.54 | -0.22 | -0.57 |
| 2024-03-31 | -0.26 | -0.54 | -0.65 | -0.03 | -0.35 |
| 2023-12-31 | -0.15 | -0.58 | -0.69 | -0.10 | -0.29 |
| 2023-09-30 | -0.13 | -0.61 | -0.78 | 0.20 | 0.07 |
| 2023-06-30 | -0.16 | -0.79 | -0.78 | 0.20 | 0.07 |
| 2023-03-31 | -0.13 | -0.69 | -1.02 | -0.00 | -0.21 |
| 2022-12-31 | -0.46 | -1.40 | -1.06 | 0.43 | -0.18 |
| 2022-09-30 | -0.42 | -1.27 | -1.06 | 0.43 | -0.18 |
| 2022-06-30 | -0.51 | -1.95 | -0.88 | -0.36 | -0.49 |
| 2022-03-31 | -0.68 | -1.00 | -1.19 | -0.25 | -0.48 |
| 2021-12-31 | -1.97 | -1.34 | 0.47 | -0.76 | |
| 2021-09-30 | -1.61 | -1.54 | 0.33 | -0.73 | |
| 2021-06-30 | -1.45 | -1.39 | 1.10 | -0.73 | |
| 2021-03-31 | -0.46 | -0.24 | 0.45 | -0.27 | |
| 2020-12-31 | -0.40 | ||||
| 2020-09-30 | -1.01 | -0.09 | -1.42 |
Gross Margins
- The gross margin for Clover Health Investments, Corp. as of June 30, 2025 is 0.26.
- The net margin for Clover Health Investments, Corp. as of June 30, 2025 is -0.02.
- The operating margin for Clover Health Investments, Corp. as of June 30, 2025 is -0.02.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
| Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
| 2025-06-30 | 0.26 | -0.02 | -0.02 |
| 2025-03-31 | 0.27 | -0.03 | -0.03 |
| 2024-12-31 | 0.16 | -0.04 | -0.04 |
| 2024-09-30 | 0.15 | -0.06 | -0.05 |
| 2024-06-30 | 0.14 | -0.08 | -0.06 |
| 2024-03-31 | 0.13 | -0.10 | -0.09 |
| 2023-12-31 | 0.09 | -0.09 | -0.10 |
| 2023-09-30 | 0.07 | -0.09 | -0.10 |
| 2023-06-30 | 0.04 | -0.09 | -0.10 |
| 2023-03-31 | 0.04 | -0.11 | -0.11 |
| 2022-12-31 | 0.01 | -0.15 | -0.14 |
| 2022-09-30 | -0.01 | -0.15 | -0.14 |
| 2022-06-30 | -0.06 | -0.16 | -0.20 |
| 2022-03-31 | -0.14 | -0.30 | -0.29 |
| 2021-12-31 | -0.11 | -0.43 | -0.47 |
| 2021-09-30 | -0.08 | -0.45 | -0.45 |
| 2021-06-30 | -0.08 | -0.52 | -0.42 |
| 2021-03-31 | 0.09 | -0.22 | -0.26 |
| 2020-12-31 | -0.20 | -0.13 | |
| 2020-09-30 | 0.16 | -0.14 | -0.14 |
Identifiers and Descriptors
| Central Index Key (CIK) | 1801170 |
Industry Groups
| SIC 6324 - Hospital and Medical Service Plans |
